Deutsche Bank’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-19,815
Closed -$108K 3734
2025
Q2
$108K Hold
19,815
﹤0.01% 3221
2025
Q1
$68.8K Buy
19,815
+277
+1% +$1.34K ﹤0.01% 3309
2024
Q4
$201K Buy
19,538
+7,753
+66% +$96.6K ﹤0.01% 3092
2024
Q3
$160K Buy
11,785
+3,512
+42% +$43.5K ﹤0.01% 3024
2024
Q2
$108K Buy
+8,273
New +$102K ﹤0.01% 3085
2023
Q4
Sell
-14,527
Closed -$92.8K 3701
2023
Q3
$92.8K Hold
14,527
﹤0.01% 3193
2023
Q2
$69.9K Buy
14,527
+6,894
+90% +$32.8K ﹤0.01% 3400
2023
Q1
$31.4K Buy
7,633
+2,186
+40% +$9.28K ﹤0.01% 3646
2022
Q4
$23.4K Buy
+5,447
New +$91.1K ﹤0.01% 3745

Other funds holding THRD

Deutsche Bank's THRD Position: Q3 2025 in Review

Deutsche Bank sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 19,815 shares — an estimated $108K sold.

Deutsche Bank first reported a position in THRD in Q4 2022 and held it in 9 quarters. The position peaked at $201K in Q4 2024. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Deutsche Bank reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Deutsche Bank sold 19,815 Third Harmonic Bio shares in Q3 2025, an estimated $108K.
  • Deutsche Bank first reported a position in Third Harmonic Bio in Q4 2022 and held it in 9 quarters.
  • Deutsche Bank's Third Harmonic Bio position peaked at $201K in Q4 2024.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Deutsche Bank's 13F filing for Q3 2025, filed 13 Nov 2025.